SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review

Nursing and Health Professions

• Kidney Disease 100%
• Literature Review 100%
• Cardiovascular Disease 100%
• Chronic Kidney Failure 100%
• Food and Drug Administration 100%
• Disease Burden 100%
• Heart Disease 100%
• Glucose Blood Level 100%
• Blood Glucose Monitoring 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Sodium Glucose Cotransporter 100%
• Maturity Onset Diabetes of the Young 100%

Medicine and Dentistry

• Cardiovascular System 100%
• Diabetes 100%
• Chronic Kidney Disease 100%
• Heart Disease 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Nephropathy 50%
• Cardiovascular Disease 50%
• Disease Burden 50%
• Maturity Onset Diabetes of the Young 50%
• Blood Glucose 50%
• Drug Administration 50%
• Feeding 50%
• Sodium Glucose Cotransporter 50%
• Blood Glucose Monitoring 50%

Keyphrases

• Chronic Kidney Disease 100%
• Heart Disease 100%
• Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 100%
• Renoprotective Effect 25%
• Diabetes 25%
• Cardiovascular Disease 25%
• Type 2 Diabetes Mellitus (T2DM) 25%
• Major Contributor 25%
• Renal Disease 25%
• Disease Burden 25%
• Patients with Diabetes 25%
• Without Diabetes 25%
• Low Blood Glucose 25%
• Cardiovascular Effects 25%
• United States Food 25%
• Blood Glucose Control 25%
• Sodium-glucose Transport Protein 2 Inhibitors 25%